Literature DB >> 6979523

Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy.

N E Gilhus, R Matre, J A Aarli.   

Abstract

The number of leukocytes and the percentage of cells in various mononuclear subpopulations were determined in 22 patients with epilepsy. The lymphocyte response to PHA were examined in the patients and in selected controls. The patients were grouped according to phenytoin treatment at present or previously, and according to the presence or absence of serum IgA depression. Patients taking phenytoin demonstrated reduced leukocyte counts. The lowest counts were found in phenytoin-treated patients with markedly reduced IgA concentrations. The number of lymphocytes were reduced more than the total leukocyte count in the patients. No significant differences were observed between patients and controls regarding percentage of cells with membrane-bound immunoglobulins, active E-rosetting cells, AET-rosetting cells, EA-rosetting cells, EAC-rosetting cells, and cells with a capacity of phagocytosis. The mean response to PHA stimulation (PHA concentration 0.6 micrograms/ml) was 4634 counts per minute in the patients and 6132 counts per minute in the controls. However, the response to this stimulation varied considerably between individuals in both groups, and the difference between the 2 groups was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979523     DOI: 10.1016/0192-0561(82)90007-8

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  8 in total

Review 1.  Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes.

Authors:  J P Uetrecht
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

Review 2.  Immunoglobulins in epilepsy.

Authors:  J A Aarli
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Increased bacterial antibody titres and IgA deficiency in epileptic patients.

Authors:  M Iivanainen; J Syrjänen; O Waltimo; V V Valtonen; N E Gilhus
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-14

4.  IgG subclasses in epileptic patients treated with phenytoin.

Authors:  N E Gilhus; T Lea
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

Review 5.  The neuroendocrine-immune axis.

Authors:  F Homo-Delarche; M Dardenne
Journal:  Springer Semin Immunopathol       Date:  1993

Review 6.  Immunological adverse effects of anticonvulsants. What is their clinical relevance?

Authors:  F De Ponti; S Lecchini; M Cosentino; C M Castelletti; A Malesci; G M Frigo
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

7.  IgA in epileptics receiving anticonvulsant therapy.

Authors:  O Meissner; H F Joubert; P H Joubert; C H van der Meyden; W Studzinski
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  The reversibility of phenytoin-induced IgA deficiency.

Authors:  N E Gilhus; J A Aarli
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.